Shares of The Home Depot (NYSE: HD) remained down 1.8% in morning hours on Wednesday after the company provided a preliminary outlook for fiscal year 2020 that was lower than what analysts had predicted.
The company reaffirmed its guidance for fiscal year 2019 and continues to expect total sales growth of approx. 1.8% and comparable sales growth of approx. 3.5%. Diluted EPS is expected to grow around 3.1% to $10.03.
Home Depot provided a preliminary fiscal year 2020 outlook which outlines total sales growth of approx. 3.5-4%. Based on data from CNBC, analysts were expecting sales growth of 4.3%. Comparable sales growth is expected to be approx. 3.5-4%.
The retailer also touched upon its One Home Depot strategy which includes investments in store enhancements, new e-commerce solutions, and delivery options. The company said it was building on its distinct competitive advantages to capitalize on a large and fragmented market opportunity and expand its leadership position for years to come.
For its most recent quarter, Home Depot reported better-than-expected earnings but missed revenue estimates. Net sales rose 3.5% to $27.2 billion while EPS grew 0.8% to $2.53. Comparable sales rose 3.6%.
Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated
The healthcare sector is going through a phase of consolidation, creating fresh opportunities for emerging companies in a market that is slowly recovering from the pandemic. Several pharmaceuticals firms have
Shares of American Airlines Group (NASDAQ: AAL) have gained 42% since the beginning of this year and 50% over the past 12 months. Despite this, there is a mixed sentiment